Projects funded by the NCN
FGF/FGFR-signalling in mediation of resistance to therapy in triple-positive breast cancer: clinical implications of PAM50 intrinsic subtypes
2020/39/B/NZ4/02696
Keywords:
FGFR ER HER2 triple-positive breast carcinoma PAM50
Descriptors:
- NZ4_5: Anatomical pathology
- NZ3_7: Signal transduction
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 20 - announced on 2020-09-15
Amount awarded: 1 998 000 PLN
Project start date (Y-m-d): 2021-10-04
Project end date (Y-m-d): 2024-10-03
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.